Madagascar vs Togo: Tuberculosis patients living with HIV receiving antiretroviral therapy
Madagascar
322 patients
in 2021
Togo
328 patients
in 2021
Madagascar rank
58th
Togo rank
57th
Tuberculosis patients living with HIV receiving antiretroviral therapy over time
- Madagascar
- Togo
How they compare
Togo currently reports 328 patients against 322 patients in Madagascar, a difference of 6 patients.
Across all 12 years both countries report, Togo has been ahead every year.
Madagascar ranks 58th and Togo ranks 57th of 183 countries.
Togo has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Madagascar | Togo | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 5 patients | 122 patients | 117 patients | Togo |
| 2010s | 91.22 patients | 457.44 patients | 366.22 patients | Togo |
| 2020s | 240 patients | 367 patients | 127 patients | Togo |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher tuberculosis patients living with hiv receiving antiretroviral therapy, Madagascar or Togo?
- Togo, at 328 patients against 322 patients in Madagascar as of 2021.
- What is the difference in tuberculosis patients living with hiv receiving antiretroviral therapy between Madagascar and Togo?
- 6 patients, with Togo ahead.
- How many years of comparable data are there for Madagascar and Togo?
- 12 years are reported by both, from 2009 to 2021.
- How do Madagascar and Togo rank globally for tuberculosis patients living with hiv receiving antiretroviral therapy?
- Madagascar ranks 58th and Togo ranks 57th of 183 countries.
- Where does this data come from?
- Joint United Nations Programme on HIV/AIDS (2026); Population based on various sources (2024) – with minor processing by Our World in Data, published as Tuberculosis patients living with HIV receiving antiretroviral therapy. Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Number of tuberculosis patients who are living with HIV and receiving antiretroviral therapy.